Ubs Group Ag Dermata Therapeutics Inc Wt Ex Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Dermata Therapeutics Inc Wt Ex stock. As of the latest transaction made, Ubs Group Ag holds 4,242 shares of DRMAW stock, worth $42. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,242
Previous 5,042
15.87%
Holding current value
$42
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DRMAW
# of Institutions
5Shares Held
191KCall Options Held
0Put Options Held
0-
Empery Asset Management, LP New York, NY175KShares$1,7500.1% of portfolio
-
Boothbay Fund Management, LLC New York, NY12KShares$1200.0% of portfolio
-
Bank Of America Corp Charlotte, NC100Shares$10.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About DERMATA THERAPEUTICS INC WT EX
- Ticker DRMAW
- Sector Healthcare
- Industry Biotechnology